Walaphage G2 Forte 2mg/1000mg Tablet is a combination oral antidiabetic medication containing Glimepiride 2mg and Metformin 1000mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta cells to enhance insulin secretion, thereby lowering blood glucose levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, promoting better glucose uptake by tissues. This dual-action formulation is designed to achieve superior glycemic control in patients inadequately managed by diet, exercise, and monotherapy. Walaphage G2 Forte is typically prescribed when monotherapy with either agent is insufficient or when combination therapy is deemed necessary for optimal control. It is important to administer the tablet with meals to reduce gastrointestinal side effects commonly associated with Metformin, such as nausea and diarrhea. Patients should be regularly monitored for blood glucose levels, renal function, and potential adverse effects including hypoglycemia, lactic acidosis, and gastrointestinal disturbances. Contraindications include severe renal impairment, metabolic acidosis, and hypersensitivity to either component. This combination therapy should be used under strict medical supervision with appropriate lifestyle modifications to achieve effective and safe diabetes management.